Evaluation of Efficacy of 20 µg/ml rhNGF New Formulation (With Anti-oxidant) in Patients With Stage 2 and 3 NK
Clinical trial NCT02227147 · COMPLETED
Trial details
- NCT number
- NCT02227147
- Sponsor
- Dompé Farmaceutici S.p.A
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2016-06-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.